Continuing HIV therapy in the ICU
The risks and benefits of stopping antiretroviral therapy in patients admitted to the ICU are largely unmeasured. In many cases therapy has to be stopped, as parenteral preparations are unavailable for all but one of the antiretroviral agents. Stopping treatment suddenly may be associated with incre...
保存先:
| 出版年: | Crit Care |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2001
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11737898/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1040 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|